TITLE

Monsanto, Pharmacia to Merge; Spin Off Agchems

AUTHOR(S)
Westervelt, Robert
PUB. DATE
January 2000
SOURCE
Chemical Week;1/5/2000, Vol. 162 Issue 1, p9
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Announces the merger plan of Monsanto company and Pharmacia & Upjohn company. Details on the merger agreement; Terms of the deal; Information on both companies; Update on the corporate spin-off of the agriculture chemical unit of Monsanto.
ACCESSION #
2667498

 

Related Articles

  • Business & Finance. Kilborn, Robert; Carden, Lance // Christian Science Monitor;12/21/99, Vol. 92 Issue 19, p24 

    Reports business news stories, including a proposed merger between Monsanto Corp. and Pharmacia & Upjohn.

  • Monsanto to merge with P&U. Niiler, Eric // Nature Biotechnology;Feb2000, Vol. 18 Issue 2, p141 

    Reports on the merger between biotechnology company Monsanto Co. and pharmaceutical company Pharmacia & Upjohn Inc. Terms of the deal; Benefits derived by Monsanto from the deal; Details about Monsanto.

  • M&A Benchmarks.  // Global Finance;Feb2000, Vol. 14 Issue 2, p26 

    Provides information on merger and acquisition activities in 1999. Top acquisition targets; Top merger advisers; Information on the merger of Monsanto and Pharmacia & Upjohn.

  • SHAREHOLDERS APPROVE PHARMACIA-MONSANTO MERGER. Westervelt, Robert // Chemical Week;3/29/2000, Vol. 162 Issue 13, p24 

    Reports on the merger of Monsanto and Pharmacia & Upjohn approved by their shareholders. Expected closing of the merger; How the combined company will be called; Sales of the combined company in 1999; Executive who will lead the combined organization.

  • Merger scoreboard: Monsanto and P&U agree, Abbott thwarted, Pfizer and W-L battle in court.  // Medical Marketing & Media;Jan2000, Vol. 35 Issue 1, p8 

    Reports on the merger between Monsanto Co. and Pharmacia and Upjohn Inc. $26.6 billion stock exchange deal on a share for share basis; Size of combined work force and research budget; Executive positions; Thwarted merger between Abbott Laboratories and Alza over regulatory issues.

  • Thomson Financial Securities Co. Database.  // Mergers & Acquisitions Report;01/03/2000, Vol. 13 Issue 1, p6 

    Presents a summary of United States public merger activity greater than $100 million in 1999. MYR Group Inc. and GPU Inc.; Pharmacia & Upjohn and Monsanto Co.; Plasma-Therm Inc. and Oerlikon-Buehrle; Deal information.

  • Pharmacia seeks shop to lead branding effort. Goetzl, David; Bulik, Beth Snyder; Petrecca, Laura // Advertising Age;2/28/2000, Vol. 71 Issue 9, p97 

    This article focuses on the speculation that Pharmacia & Upjohn is searching for an advertising agency for its corporate branding assignment. The new assignment is believed to be for the combined company that will be created by Pharmacia's merger with Monsanto Corp. One agency said the...

  • Trying to Recoup the Cost Of Lost Opportunities. Sikora, Martin // Mergers & Acquisitions: The Dealermaker's Journal;Mar2000, Vol. 35 Issue 3, p12 

    Reports on the decision of Scott, Mississippi-based Delta and Pine Land Co. to file a lawsuit against Monsanto Co. following the failure of merger negotiations between the companies. Effect of the negotiation failure on Delta's stocks; Amount sought by Delta from Monsanto; Effect of the lawsuit...

  • F.Y.I.  // Advertising Age;1/31/2000, Vol. 71 Issue 5, p96 

    Presents an update related to advertising in the U.S. as of January 2000. Merger between Monsanto Co. and Pharmacia & Upjohn; Appointment of Martin Levine at BBDO Worldwide subsidiary PentaMark; Value of the advertising account awarded by Smith & Harroff to Greer, Margolis, Mitchell, Burnes &...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics